X

pharmaceuticals

IPO Alert: Third Harmonic files to go public. Here’s what you need to know

IPO activity has started gaining steam after falling significantly in the first half, in line with the global trend, but…

Pfizer (PFE): A look at the headwinds and tailwinds this pharma giant faces in the near term

Shares of Pfizer Inc. (NYSE: PFE) were down on Monday. The stock has dropped 15% year-to-date and there is a…

Trxade will focus more on core biz, connect with POS systems: CEO Suren Ajjarapu

Trxade Health Inc. (NASDAQ: MEDS) has been on a mission to digitalize the retail pharmacy experience by providing a platform…

Eli Lilly and Company (LLY) Earnings: 2Q22 Key Numbers

Eli Lilly and Company (NYSE: LLY) reported second quarter 2022 earnings results today. Worldwide revenue decreased 4% to $6.49 billion compared…

CVS Health Corporation (CVS) Q2 2022 Earnings: Key financials and quarterly highlights

CVS Health Corporation (NYSE: CVS) reported second quarter 2022 earnings results today. Total revenues increased 11% year-over-year to $80.6 billion.…

ABBV Earnings: Highlights of AbbVie’s Q2 2022 financial results

Pharmaceutical company AbbVie, Inc. (NYSE: ABBV) has reported double-digit growth in second-quarter adjusted earnings, reflecting an increase in revenues. The…

Bristol Myers Squibb (BMY) Q2 2022 Earnings: Key financials and quarterly highlights

Bristol Myers Squibb (NYSE: BMY) reported second quarter 2022 earnings results today. Total revenue grew 2% year-over-year to $11.9 billion.…

Pfizer (PFE) Q2 2022 Earnings: Key financials and quarterly highlights

Pfizer Inc. (NYSE: PFE) reported second quarter 2022 earnings results today. Total revenues increased 47% year-over-year to $27.7 billion. Reported…

MEDS Earnings: Trxade Health Q2 revenues surge 73% amid continued user growth

Trxade Health Inc (NASDAQ: MEDS), a leading health service IT company, reported a sharp increase in its second-quarter 2022 revenues.…

Abbott Laboratories (ABT) Earnings: 2Q22 Key Numbers

Abbott Laboratories (NYSE: ABT) reported second quarter 2022 earnings results. Total sales increased 10.1% year-over-year to $11.3 billion. On an…

JNJ Earnings: Johnson & Johnson reports higher sales and adj. profit for Q2

Johnson & Johnson (NYSE: JNJ) reported an increase in sales and adjusted profit for the second quarter of 2022 when strong…

What awaits Johnson & Johnson (JNJ) beyond consumer business spinoff

Johnson & Johnson (NYSE: JNJ) is probably the most diversified healthcare firm that owns several popular consumer brands, which have…

Despite generic threat, AbbVie (ABBV) remains a good long-term bet

Biopharmaceutical firm AbbVie Inc. (NYSE: ABBV) is currently at a crucial juncture as it strives to overcome the threat from…

ANGO Earnings: AngioDynamics swings to profit in Q4; revenues beat estimates

AngioDynamics Inc. (NASDAQ: ANGO) on Tuesday reported a modest profit for the fourth quarter of 2022 compared to breakeven last…

Abbott Laboratories (ABT) stock remains a compelling buy. Here’s why

Like most healthcare-related businesses, Abbott Laboratories (NYSE: ABT) has been operating near full capacity for quite some time, with its…

Walgreens Boots Alliance (WBA) Q3 profit drops on lower revenues; results beat

Walgreens Boots Alliance, Inc. (NASDAQ: WBA) on Thursday said its third-quarter revenues decreased. As a result, the healthcare service company's…

ANGO Stock: Is it the right time to invest in AngioDynamics now?

The performance of AngioDynamics, Inc. (NASDAQ: ANGO) has not been very impressive lately, despite being part of a rapidly growing…

Stock Watch: Intuitive Surgical (ISRG) remains a good bet despite slowdown

Intuitive Surgical, Inc. (NASDAQ: ISRG) is a market leader in the manufacturing and distribution of robotics-assisted surgical systems. The company’s products,…

OptMed all set for $24 million IPO. Here’s what you need to know

As IPO activity picks up momentum after a lull, technology and healthcare companies are dominating the scene as usual. The…

Stock Watch: Key factors to consider before investing in Medtronic (MDT)

More than two years into the pandemic, the healthcare sector remains under stress due to continuing COVID care activities and…

MDT Earnings: Highlights of Medtronic’s Q4 2022 results

Medical device maker Medtronic plc (NYSE: MDT) has reported an increase in profit for the fourth quarter of 2022, despite…